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Abstract
The N-Methyl-D-Aspartate (NMDA) receptors – neuronal nitric oxide syn-
thase (nNOS) pathway is involved in the ventilatory response to hypoxia. The
objective was to assess the possible effect of erythropoietin deficiency and
chronic exposure to hypoxia on this pathway during ventilatory response to
acute hypoxia. Wild-type (WT) and erythropoietin-deficient (Epo-TAgh) male
mice were exposed (14 days) either to hypobaric hypoxia (Pb = 435 mmHg)
or to normoxia. The ventilation was measured at 21% or 8% O2 after injec-
tion of vehicle (NaCl), nNOS inhibitor (SMTC) or NMDA receptor antago-
nist (MK-801). Nitric oxide production and the expression of NMDA
receptor and nNOS were assessed by real-time RT-PCR and Western blot
analyses in the medulla. At rest, Epo-TAgh mice displayed normal ventilatory
parameters at 21% O2 but did not respond to acute hypoxia despite a larger
expression of NMDA receptors and nNOS in the medulla. Ventilatory accli-
matization to hypoxia was observed in WT but was absent in Epo-TAgh mice.
nNOS inhibition blunted the hypoxic ventilatory acclimatization of WT mice
without any effect in Epo-TAgh mice. Acute hypoxic ventilatory response
(HVR) was increased after chronic hypoxia in WT but remained unchanged
in Epo-TAgh mice. Ventilatory response to acute hypoxia was modified by
MK-801 injection in WT and Epo-TAgh mice. The results confirm that ade-
quate erythropoietin level is necessary to obtain an appropriate HVR and a
significant ventilatory acclimatization to hypoxia. Furthermore, erythropoietin
plays a potential catalyzing role in the NMDA-NO central pathway during the
ventilatory response and acclimatization to hypoxia.
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
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Introduction
The acute hypoxic ventilatory response (HVR) is char-
acterized by hyperventilation followed by a relative
ventilatory decline (Teppema and Dahan 2010). Then, a
time-dependent increase in ventilation occurs after few
hours to several weeks. This ventilatory acclimatization to
chronic hypoxia (VAH) is defined by an increase in rest-
ing ventilation and in the sensitivity of the respiratory
control system (Olson and Dempsey 1978; Bisgard and
Neubauer 1995; Prabhakar et al. 1996; Bisgard 2000;
Gozal et al. 2000; Powell et al. 2000). This increase in
sensitivity includes an enhanced O2 peripheral chemosen-
sitivity (Bisgard 2000; Powell 2007) and an increase in
central responsiveness to peripheral chemoreceptors input
(Powell et al. 2000). Furthermore, the initial increase in
HVR contributes to VAH and its magnitude (Bisgard and
Neubauer 1995; Powell et al. 1998).
The hypoxia-inducible factor-1 (HIF-1) is the most
important protein regulating homeostasis in hypoxia
(Gassmann and Soliz 2009). Under chronic hypoxia, HIF-
1 is stabilized and regulates the activation of more than
100 target genes including erythropoietin (Epo) (Yeo
et al. 2004; Fandrey et al. 2006; Gassmann and Soliz
2009), the main regulator of red blood cell production,
allowing the increase in O2 carrying capacity under
chronic hypoxia (Gonzalez et al. 1998; Favret et al. 2001;
Robach et al. 2004). Epo is also synthesized by the central
nervous system (Digicaylioglu et al. 1995). Furthermore,
it was suggested that Epo receptors (Epo-R) are largely
distributed in respiratory areas of the brainstem and
peripheral carotid bodies (Soliz et al. 2005). While the
observation of Soliz and colleagues must be used with
caution due to the lack of specificity of the antibody used
(Kirkeby et al. 2007), other studies showed that cells in
the nervous system express both Epo and its receptor
(Masuda et al. 1994; Siren et al. 2001). Therefore, Epo
could act on ventilatory control under hypoxic conditions
(Soliz et al. 2005) and play a key role for acclimatization
to hypoxia in mice (Soliz et al. 2007). Chronic hypoxia
leads to an increase in ventilation in wild-type (WT)
mice, which is reduced after neuronal nitric oxide syn-
thase (nNOS) inhibition (El Hasnaoui-Saadani et al.
2007). Moreover, it has been proposed that activation of
N-Methyl-D-Aspartate receptors (NMDA-R) could be
involved in the early HVR (Gozal et al. 2000). When
glutamate binds to NMDA-R, the intracellular calcium
concentration increases, which may activate nNOS and
induce a rise in nitric oxide (NO) production, then act as
an excitatory neurotransmitter in HVR (Ogawa et al.
1995). Therefore, chronic hypoxia was shown to stimulate
the central pathway including NMDA-R, nNOS, and NO
production. In addition, Epo was shown to increase NO
production in rat hippocampus by activating voltage-
gated Ca2+ channels, but not through NMDA receptors
(Yamamoto et al. 2004).
Considering the effects of the NMDA-R-nNOS pathway
on VAH in WT mice (El Hasnaoui-Saadani et al. 2007)
and the possible link between Epo and NO production,
we aimed to investigate the role of Epo and its interaction
with the central NMDA-NO central pathway on HVR in
mice exposed to either chronic normoxic (NX-exposed)
or hypoxic (HX-exposed) conditions. We supposed that
Epo could play a key role in VAH and HVR mechanisms
by increasing ventilatory responses to hypoxia through
the central NMDA-NO pathway. To test our hypothesis,
we measured ventilatory parameters in normoxia and
acute hypoxia after injection of vehicle, NMDA-R antago-
nist (MK-801) and nNOS inhibitor (SMTC) in WT and
Epo-deficient (Epo-TAgh) NX-exposed or HX-exposed
mice.
Methods
Ethics statement
Experimental protocols were approved by The Ethics
Committee in Animal Experiment Charles Darwin (Ce5/
2011/05), done in accordance with the European Com-
munities Council Directive of September 22, 2010 (2010/
63/EU) for animal care, and conducted in accordance
with French laws for animal care (authorization number:
A-93-086 for NV and A-93-072 for AP).
Animals
All experiments were performed in WT (n = 64) and
Epo-TAgh (n = 52) male adult littermates (10 weeks at
the beginning of the study) born from Bl6/CBA strain.
The Epo-TAgh mice present a targeted disruption in the
5′ untranslated region of the Epo gene that reduces the
whole-body Epo expression (Binley et al. 2002). Mean
body weight and hematocrit was 25.2  0.5 g and 41.2
 4.4% for WT and 28.0  0.8 g and 20.7  2.2% for
Epo-TAgh mice, respectively.
Mice were exposed to either chronic normoxic
(NX-exposed) or hypoxic (HX-exposed) conditions. The
HX-exposed group was housed for 14 days in a hypobaric
chamber maintained at a pressure of 435 mmHg
(4460 m) by a vacuum source at flow rates sufficient to
prevent CO2 buildup. The chamber was returned to sea
level (760 mmHg) twice a week for 30 min to clean the
cages and to renew the water and food. The NX-exposed
group was kept outside of the hypobaric chamber at
760 mmHg. All animals were housed in a 12 h/12 h light/
dark cycles and had ad libitum access to water and food.
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Ninety-two mice were used to analyze ventilatory
parameters and 24 mice were used to quantify NMDA-R
protein and mRNA and nitrate-nitrite (NOx) as markers
of nitric oxide (NO) production.
Ventilatory parameters
In non-anesthetized and unrestrained mice, breathing
parameters were recorded by whole-body plethysmography
as previously described (Bartlett and Tenney 1970; Menuet
et al. 2011). Briefly, the plethysmographic chamber
(200 mL) was connected to a differential pressure trans-
ducer (model DP 45-18; Validyne Engineering Northridge,
CA), which measured pressure fluctuations within the
closed chamber relative to a reference chamber of the same
volume. Breathing parameters were recorded by a BIOPAC
data analysis system (BIOPAC System Inc., Santa Barbara,
CA). Two or three days before plethysmographic record-
ings for the NX-exposed groups or before entering the hyp-
obaric chamber for HX-exposed groups, mice were
accustomed to stay in the plethysmograph chamber to
reduce stress effect on breathing. To check the acute venti-
latory responses to hypoxia (Fig. 1), air was replaced by
hypoxic gas mixture (O2 8%, 5 min). Routinely, WT and
Epo-TAgh mice were alternatively recorded and subjected
to the same environmental challenges. Only periods of
breathing without body movements were analyzed. We
measured respiratory frequency (fR, in cycle per min,
cmin1), tidal volume (VT, lL) normalized as the ratio VT
divided by body weight (VT, lLg1), and minute ventila-
tion ( _VE, mLg1min1). HVR was calculated as the differ-
ence in _VE between 8% and 21% O2. VAH was calculated
as the difference in _VE in normoxic conditions (21% O2)
between NX-exposed and HX-exposed groups.
Drugs
In order to test the role of medullary NO production,
mice were subjected to a single intraperitoneal (i.p.) injec-
tion of either vehicle (NaCl; n = 10 for WT NX-exposed
and for Wt HX-exposed; n = 8 for Epo-TAgh NX-exposed
mice and for Epo-TAgh HX-exposed mice), MK-801
(Sigma Aldrich, St. Louis, MO, NMDA-R antagonist,
3 mgkg1; n = 8 for WT NX-exposed and for Wt HX-
exposed; n = 6 for Epo-TAgh NX-exposed mice and for
Epo-TAgh HX-exposed mice) or SMTC (Sigma Aldrich,
nNOS inhibitor, 10 mgkg1; n = 9 for WT NX-exposed
and n = 7 for Wt HX-exposed; n = 6 for Epo-TAgh NX-
exposed mice and for Epo-TAgh HX-exposed mice).
Breathing records were performed during control period
and during the last minute of the acute hypoxic exposure.
During the control period, breathing parameters were
recorded three times at 10 min intervals and averaged. A
first set of measurement was performed prior drug injec-
tion and a second one was performed 30 min (SMTC) or
1 h (MK801) after injection.
Biochemical analysis
As previously reported (El Hasnaoui-Saadani et al. 2007,
2009), at the end of either chronic normoxic or hypoxic
exposure, mice were killed by cervical elongation and
then beheaded. The brain was rapidly removed and the
medulla quickly frozen in liquid nitrogen and stored at
80°C until use.
Medulla RNA Extraction and Real-Time RT-PCR
Total RNA was isolated from the medulla using TRIZOL
Reagent (Invitrogen, Carlsbad, CA) and digested with
RNase free DNase I (Invitrogen) for 1 h 30 min at room
temperature to remove any contaminating genomic DNA.
cDNA synthesis was performed using the SuperScript III
First-Strand Synthesis System for RT-PCR (Invitrogen)
according to the manufacturer’s instructions (5 lg total
RNA/20 lL cDNA synthesis reactions, 50 lmol/L oligo
(dT)20, 10 mmol/L dNTP mix).
Then, duplicate real-time PCR was performed on
generated cDNA using the Light Cycler FastStart DNA
Master SYBR Green I (Roche Biochemicals, Stockholm,
Sweden) and gene-specific PCR primers (El Hasnaoui-
Saadani et al. 2007) for quantitative analyses of genes of
interest. PCR amplifications were performed according
to the manufacturer’s instructions. The results were rep-
resented as threshold cycle numbers (Ct values). Control
cDNA of normoxic WT mice medulla was used to cre-
ate standard curves. Relative amounts of mRNA, nor-
malized by b-actin were calculated from Ct values,
Figure 1. Study design. The ventilatory parameters were evaluated
by plethysmographic approach in non-anesthetized and
unrestrained mice exposed to either chronic normoxic (NX-exposed)
or hypoxic (HX-exposed) conditions. The acute ventilatory response
to hypoxia was checked by replacing air (control) by hypoxic gas
mixture (hypoxia, O2 8 %, 5 min) before (vehicle) and after drug
injection.
ª 2014 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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according to the manufacturer’s description (Roche Bio-
chemicals).
Medulla Protein Extraction and Western Blot
Analysis
Twenty-four medulla samples of WT and Epo-TAgh mice
NX-exposed or HX-exposed (six mice for each group)
were homogenized in ice-cold buffer supplemented with a
protease inhibitor cocktail (Sigma Aldrich): (a) 20 mmol/L
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 1.5
mmol/L MgCl2, 0.2 mmol/L ethylenediaminetetraacetic
acid, 0.1 mmol/L NaCl, 0.2 mmol/L dithiothreitol,
0.5 mmol/L NaVO4, pH 7.5 for NMDA-R measurement,
(b) 50 mmol/L Tris HCl, 150 mmol/L NaCl, 1% Triton X-
100, 0.1% sodium deoxycholate, pH 7.2 for nNOS mea-
surements. Homogenates were centrifuged at 10.000g for
30 min at 4°C. Then, supernatants were collected and
stored at 20°C until use.
Protein of each studied sample (100 lg) was separated
by electrophoresis on 7.5% (nNOS) or 10% (NMDA-R)
sodium dodecyl sulphate polyacrylamide gel and trans-
ferred to polyvinylidene difluoride (PVDF) membrane
(Millipore SAS, Molsheim, France). In addition, positive
controls were also loaded, and precision prestained stan-
dards were used as molecular weight markers (Bio-Rad
Laboratories, Marnes-la-Coquette, France). Membranes
were kept overnight in 5% BSA (bovine serum albumin) /
TBS (tris-buffered saline)-0.5% Tween 20 at 4°C to block
nonspecific binding. Membranes were then incubated
overnight at 4°C with each primary antibody (nNOS
[sc-648]; NMDA-R [sc-9058]; Santa Cruz Biotechnology,
Santa Cruz, CA) diluted at 1/500 in 1% BSA/TBS-0.5%
Tween 20 (TBS-T). Membranes were washed with TBS-T
and incubated for 2 h at room temperature with either
1:500 anti-rabbit or 1:500 anti-mouse IgG antibody-horse-
radish peroxidase conjugate depending on the species of
the primary antibodies (Santa Cruz Biotechnology).
Immunodetection was accomplished using ECL Western
blot analysis detection kit (Santa Cruz Biotechnology).
Membranes were then probed with anti b-actin (Santa
Cruz Biotechnology) as internal control. Densitometric
scanning and image analysis, using ImageJ (National Insti-
tute of Health, Bethesda, MD), were done to quantify the
specific protein expression of each sample compared to
internal control. Data were then expressed as the ratio of
the protein of interest density to that of the b-actin.
NOx Colorimetric Assay
The total amount of NO in the medulla samples (n = 6 for
WT and n = 6 for Epo-TAgh) was assessed by the Griess
reaction using a colorimetric assay kit (nitrate/nitrite
colorimetric assay kit; Cayman Chemical, MI) that detects
nitrite (NO2
) and nitrate (NO3
), which are stable reac-
tion products of NO. Because the relative proportion of
each metabolite may vary, the index of total NO produc-
tion is best assessed by their sum (NOx). Hence, homogen-
ates and assay procedure were carried out following the
manufacturer’s instructions. Briefly, cerebral cortex sam-
ples were homogenized in four volumes (W/V) of phos-
phate buffered saline (pH 7.6) at 4°C, ultracentrifuged at
100.000g for 60 min at 4°C. NOx determination was car-
ried out in supernatants. The nitrate reductase reaction
was first employed to convert nitrate to nitrite followed by
Griess reaction in order to measure metabolites by photo-
metric absorbance using an Enzyme-Linked Immunosor-
bent Assay plate reader. The optical density was measured
at 540 nm. The quantity of NOx detected in each sample
was compared to a nitrite standard curve. Finally, data
were expressed as the ratio of the quantity of NOx to that
of total protein.
Statistical analysis
Values are presented as mean  standard deviation (SD).
Kolmogorov–Smirnov test assessed the normality of dis-
tribution. The effects of acute hypoxia (FIO2 8% vs. 21%)
on ventilatory and biochemical parameters in WT and
Epo-TAgh mice were evaluated (i) after exposure to either
chronic normoxic or hypoxic conditions and/or (ii) drugs
injection (NaCl, SMTC or MK-801, Fig. 1). Differences
were tested by a multivariate analysis of variance
(MANOVA) with Greenhouse and Geisser adjustments.
Newman–Keuls post hoc tests were used to assess specific
differences between groups. All analyses were performed
with the Statistica software (Stat Soft, Tulsa). Differences
were considered significant when P < 0.05.
Results
Effect of Epo deficiency and exposure to
chronic hypoxia on normoxic ventilatory
parameters
At baseline, ventilatory parameters were similar in WT
and Epo-TAgh mice (Table 1) and rectal temperatures
were not different (35.1  0.2°C and 35.2  0.9°C,
respectively). After 14 days in the hypobaric chamber, _VE
of WT mice was significantly higher (VAH) as compared
to NX-exposed mice. This increase in _VE was mediated
exclusively by an increase in VT, as breathing frequency
was unaltered in HX-exposed mice. In contrast, ventila-
tory parameters were not altered in Epo-Tagh
HX-exposed mice. Rectal temperatures of WT and Epo-
TAgh mice were not modified after chronic hypoxia
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(35.7  0.6°C and 35.7  0.7°C, respectively) as com-
pared to mice housed in normoxia.
Effect of exposure to chronic hypoxia on
HVR
In WT NX-exposed mice, exposure to acute hypoxia (8%
O2) led to an increase in VT and _VE (HVR) whereas Epo-
TAgh mice did not respond (Table 1, Fig. 2). HX-exposed
WT mice showed a larger HVR than without acclimatiza-
tion (Table 1, Fig. 2). In Epo-TAgh HX-exposed mice, acute
hypoxia (8% O2) led to an increase in fR and _VE (Table 1).
Effect of injection of nNOS inhibitor and
NMDA receptor antagonist on normoxia-
exposed mice
In WT and Epo-TAgh mice housed in normoxic condi-
tions, injection of SMTC had no effect on ventilatory
parameters (Table 1) whereas VT was significantly
increased after MK-801 injection in both mice strains.
During the acute hypoxic challenge, SMTC had no effect
on HVR (Table 1, Fig. 2), while it was completely abol-
ished by MK-801 in WT NX-exposed mice.
Effect of interaction between drug injection
and exposure to chronic hypoxia
Effect of SMTC after exposure to chronic hypoxia
SMTC injection reduced the increase in _VE induced by
14 days of acclimatization to chronic hypoxia in WT mice
(Table 1) and tended to decrease the VAH (P = 0.07,
Fig. 3). However, HVR persisted without change after
nNOS inhibition (Fig. 2) despite a slight reduction in VT
and _VE as compared to vehicle in WT mice HX-exposed
during acute response to hypoxia (FIO2 = 8%, Table 1).
No effect of SMTC was reported on VAH in HX-exposed
Epo-TAgh mice after 14 days of chronic hypoxia (Table 1,
Fig. 3).
Table 1. Ventilatory parameters in wild-type and Epo-TAgh mice exposed either to normoxic (NX-exposed) or hypoxic (HX-exposed) conditions
tested in normoxia (FIO2 = 21%) and acute hypoxia (FIO2 = 8%).
Acclimatization
FIO2
(%)
Wild type mice Epo-TAgh mice
NaCI SMTC MK-801 NaCI 8M1C MK-801
_VE
(mLg1min1
NX-exposed 21 2.26  0.48 2.20  0.57 2.90  0.38 2.17  0.53 2.15  0.53 2.72  0.16
8 3.61  1.141 3.46  0.601 2.03  0.503 2.59  0.44 3.04  0.27 3.04  0.451
HX-exposed 21 3.51  0.772 2.87  0.81 3.16  0.83 2.57  0.37 2.45  0.36 3.37  0.29
8 7.27  1.071,2 6.31  0.741,2,3 3.15  0.662,3 3.86  0.521,2 3.60  0.401 3.72  1.14
VT (lLg1) NX-exposed 21 8.63  1.26 7.20  1.43 10.97  1.153 7.62  1.09 7.61  1.34 12.32  0.973
8 11.28  2.371 12.19  1.831 9.12  1.37 7.68  1.28 9.03  0.57 9.08  2.061
HX-exposed 21 11.96  1.242 9.55  1.662,3 14.27  3.082,3 9.13  1.97 7.95  0.68 17.32  2.612,3
8 18.05  2.381,2 15.76  1.261,2,3 11.38  2.042,3 10.46  1.552 9.25  0.80 16.14  4.202,3
fR (cmin1) NX-exposed 21 261  34 307  53 268  47 284  54 282  47 221  19
8 318  54 284  28 226  563 338  34 337 18 244  273
HX-exposed 21 292  49 293  55 222  343 289  48 309  42 198  343
8 404  211,2 407  201,2 280  493 370  111 389  261 227  343
Values are mean  SD of ventilation ( _VE), tidal volume (Vt) and respiratory frequency (fR). Significant differences are indicated as follows.
1P < 0.05 versus 21% for the same group.
2P < 0.05 effect of exposure to chronic hypoxia in the same strain and the same FIO2.
3P < 0.05 versus NaCI in the same strain for the same FIO2.
Figure 2. Effect of exposure to chronic hypoxia and drugs
injections on HVR. Hypoxic ventilatory response was the difference
between the recorded value at 8% O2 and 21% O2. Given values
are obtained before and after drugs injections (NaCl, SMTC or
MK-801). Values are means  SD. ¤P < 0.05 effect of exposure to
chronic hypoxia in the same strain. #P < 0.05 versus NaCl in the
same strain. $P < 0.05 versus wild-type (WT) animals.
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Effect of MK-801 after exposure to chronic
hypoxia
MK-801 injection reduced the VAH induced by expo-
sure to chronic hypoxia in WT mice (Table 1, Fig. 3).
The injection of MK-801 induced a significant decrease
in fR and an increase in VT as compared to vehicle in
HX-exposed WT and Epo-TAgh mice at 21% O2
(Table 1). During acute hypoxia (8% O2), MK-801
injection led to a significant decrease in _VE, VT and fR
in HX-exposed WT mice as compared to vehicle
(Table 1). In HX-exposed Epo-TAgh mice, _VE was
unchanged as compared to vehicle despite an increase
in VT and a decrease in fR (Table 1). HVR after expo-
sure to chronic hypoxia was totally abolished after MK-
801 injection as compared to vehicle in WT mice
(Fig. 2).
NMDA-R and nNOS expression in medulla
At baseline, in the medulla of mice housed in normoxia,
NMDA-R and nNOS mRNA and protein expressions
(Table 2) were higher in Epo-TAgh mice than in WT
mice. After exposure to chronic hypoxia, mRNA and pro-
tein levels of NMDA-R were significantly higher in WT
mice as compared to mice housed in normoxia, while it
remained unchanged in Epo-TAgh mice. The nNOS
mRNA and protein levels were higher in WT whereas
only nNOS protein was higher in Epo-TAgh mice exposed
to chronic hypoxia compared with those housed in norm-
oxia (Table 2).
NO production
Concentrations of NO metabolites were the same between
WT and Epo-TAgh mice housed in normoxia (Table 2).
After 14 days of hypobaric hypoxia, NO metabolites were
higher than in normoxia in both strains of mice and were
significantly larger in Epo-TAgh mice than in WT mice
(Table 2).
Discussion
This study was designed to evaluate the interaction
between Epo and NMDA-NO central pathway in ventila-
tory response to acute hypoxia and the modulation of
this phenomenon by prior exposure to chronic hypoxia.
Our results confirm that adequate Epo level is necessary
to obtain normal HVR and VAH. Moreover, our results
show that MK-801 blocks HVR and VAH and that SMTC
have only an effect on VAH, suggesting that the effect of
NMDA and NO pathways might be independent.
Methodological considerations
Experiments were performed on Epo-deficient SV-40 T
antigen mice that display a whole-body reduced Epo
expression (Binley et al. 2002). The Epo-deficient mice
display also a very low hematocrit (around 20%) and did
not develop polycythemia after exposure to chronic
hypoxia contrary to WT mice (Macarlupu et al. 2006b).
Indeed, hemoglobin concentration as well as hematocrit
did not change significantly after 14 days of chronic
P = 0.07
Figure 3. Effect of chronic hypoxia and drug injections on VAH. Difference in minute ventilation at 21% O2 between mice housed in
normoxia and mice exposed to chronic hypoxia in wild-type (WT) and Epo-TAgh mice, representing the ventilatory acclimatization to
chronic hypoxia (VAH) and after drug injections (NaCl, SMTC or MK-801). #P < 0.05 versus NaCl in the same strain. Values are
means  SD.
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hypoxia compared to normoxic values (Macarlupu et al.
2006b). Therefore, we cannot exclude that the observed
effects are due to chronic anemia or the combined effect
of Epo deficiency and anemia.
It is known that carotid bodies contribute to Epo regu-
lation of ventilation (Soliz et al. 2005). As the pharmaco-
logical substances used in this study were injected
intraperitoneally we cannot exclude a systemic effect,
which could not only be limited to the medulla but could
also affect peripheral chemoreceptors or other areas of
the central nervous system. Consequently, we cannot
determine which tissues are responsible for the difference
observed in the ventilatory response of Epo-TAgh mice
(medulla and/or carotid bodies).
Effect of Epo deficiency under normoxic
conditions
Epo deficiency did not modify breathing parameters and
central temperature in resting condition (21% O2) at least
in male mice. In Epo-deficient mice, no significant HVR
was found. These results confirm that Epo is necessary to
obtain a correct HVR. Indeed, it has been previously pro-
posed that Epo exerts a key role in HVR (Soliz et al.
2005) and improves this response in female mice (Soliz
et al. 2009).
Effect of exposure to chronic hypoxia on NO
pathway in WT and Epo-deficient mice
In WT mice, exposure to chronic hypoxia leads to an
increase in NMDA-R expression and NO production in
the medulla. These results suggest that the intracellular
signaling pathways that are used by Epo at the nervous
system level are similar to those implicated in tissue pro-
tection. Indeed, Epo modulates the activity of calcium
channels through phospholipase C, thereby reducing the
release of excitatory neurotransmitters and increasing NO
production (Brines and Cerami 2005). The decrease in the
excitatory neurotransmitters could be at the origin of the
observed increase in NMDA-R expression in WT mice, in
order to increase the effectiveness of the neurotransmitter.
In Epo-TAgh mice, the absence of modifications in
NMDA-R expression after exposure to chronic hypoxia
suggests that sufficient level of Epo is necessary to main-
tain a correct release of neurotransmitters. Indeed, Epo
directly influences neurotransmitter release as well as neu-
ronal activity (Koshimura et al. 1999; Kawakami et al.
2000). The increase in NO production in Epo-deficient
mice could suggest that other pathways could be involved.
Effect of exposure to chronic hypoxia on
VAH and HVR in WT and Epo-deficient mice
As already shown by our team (El Hasnaoui-Saadani
et al. 2007) and others (Powell et al. 1998), acclimatiza-
tion to chronic hypoxia leads to: (i) a significant increase
in ventilation (VAH) mainly due to an increase in VT
(Table 1) and (ii) a significant increase in HVR (Fig. 3).
In WT mice, plasma Epo is known to increase HVR by
stimulating peripheral chemoreceptors (Soliz et al. 2005).
In Epo-TAgh mice, chronic hypoxia did not induce a sig-
nificant VAH despite unchanged NMDA-R but increased
nNOS expression and NOx production in the medulla
(Table 2). Nevertheless, Epo-TAgh mice displayed a slight
but significant increase in VT and _VE at 8% O2 after
chronic hypoxia exposure. These results suggest a poten-
tial role of nNOS and NOx in HVR after exposure to
chronic hypoxia in Epo-TAgh mice that partially compen-
sates the lack of high Epo concentration. Another expla-
nation could be that 8% O2 was too severe for these
transgenic mice to increase ventilation and that the
related energetic cost of breathing was too high, given
their low oxygen-carrying capacity. Exposure to chronic
Table 2. Expression of mRNA and protein of NMDA-R1 and nNOS in the medulla and NO production in WT and Epo-TAgh mice exposed
either to normoxic (NX-exposed) or hypoxic (HX-exposed) conditions.
Wild-type Epo-TAgh
NX-exposed HX-exposed NX-exposed HX-exposed
NMDA-R1 mRNA/b-actin 8.26  1.39 20.81  1.971 26.62  0.932 17.67  2.21
NMDA-R1 protein/b-actin 2.94  0.16 4.14  0.601 4.09  0.192 4.16  0.99
nNOS mRNA/b-actin 0.96  0.19 1.72  0.231 2.30  0.212 2.25  0.05
nNOS protein/b-actin 0.57  0.07 1.71  0.111 1.03  0.122 2.01  0.361
NOx (lmollL1) 103  6 146  41 85  6 242  201,2
Values are Mean  SD of the expression of mRNA and protein of NMDA-R1 and nNOS and production of NO (NOx, sum of NO2, and
NO3
). Significant differences are indicated as follows.
1P < 0.05 effect of exposure to chronic hypoxia in the same strain.
2P < 0.05 versus wild-type strain with the same exposition (NX or HX).
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hypoxia did not affect rectal temperature neither in WT
nor in Epo-TAgh mice. Therefore, metabolic rate seems
unaffected by chronic hypoxia and/or Epo deficiency.
Effect of drug injection on VAH and HVR in
WT mice
Effects of nNOS on ventilatory control in hypoxia
The present results confirm previous studies from our
group (El Hasnaoui-Saadani et al. 2007) and support the
idea that the increase in nNOS expression leading to a
rise in NO modulates the ventilatory pattern mainly
through an increase in Vt and contributes to VAH with-
out any effect on HVR in nonacclimatized WT mice (for
more details see El Hasnaoui-Saadani et al. (2007)).
Effects of NMDA-R on ventilatory control in
hypoxia
It was clearly demonstrated that in the first stages of
hypoxia, peripheral chemoreceptor stimulation elicits a
rapid ventilatory increase by enhancing glutamate release
(Mizusawa et al. 1994) and activation of postsynaptic
NMDA-R in the nucleus of the solitary tract (Ohtake
et al. 1998). Indeed, Ohtake et al. (1998) have shown that
NMDA-R protein level increased after hypoxic exposure
in the nucleus of the solitary tract of adult rats, which is
in agreement with a role of NMDA in HVR in mammals
(Gozal et al. 2000). These results were confirmed by our
observation in WT mice with or without exposure to
chronic hypoxia. Reid and Powell (2005) also demon-
strated that systemic NMDA-R blockade (MK801) elimi-
nated HVR in normoxic and chronically hypoxic rats.
The rise in NMDA-R in chronically hypoxic mice could
explain the larger response to NMDA-R blockade on ven-
tilatory parameters after acclimatization. Taken together,
these results suggest that NMDA-R are involved in HVR
after chronic hypoxia and support the hypothesis of
NMDA-R plasticity with acclimatization to hypoxia.
Moreover, the activation of NMDA-R, enhancing HVR,
seems also to be linked to nNOS expression but only after
exposure to chronic hypoxia. Indeed, a small but signifi-
cant decrease in ventilation was observed after SMTC
injection in acclimatized WT mice exposed to acute
hypoxia, suggesting that nNOS was partially involved in
HVR after acclimatization. Therefore, our results suggest
that, in chronically hypoxic mice, the increase in NMDA-
R may induce a rise in intracellular calcium leading to
calmodulin release, which could reinforce the role of
nNOS in VAH after acclimatization to hypoxia. Surpris-
ingly, MK-801 induced a significant increase in VT in WT
mice before and after acclimatization in normoxic condi-
tions suggesting that compensatory mechanisms over-
whelmed NMDA-R inefficiency.
Effect of drug injection on VAH and HVR in
Epo-deficient mice
Role of nNOS and NOx on ventilatory control in
hypoxia
In Epo-TAgh mice housed at sea level, we observed that
SMTC injection had no effect on ventilatory parameters
(Table 1) despite a larger expression of nNOS in the
medulla as compared to WT mice. Ward et al. (2005)
showed that hypoxia induced a significant increase in
nNOS protein levels (~10-fold) whereas NOS activity
increased less than 1.5-fold suggesting a difference
between the expression of the protein and its activity.
Our results suggest that the activity of nNOS in the
medulla of Epo-TAgh mice could be lower than in WT
mice, probably due to Epo deficiency, and, therefore, lead
to a lower HVR. However, the slight but significant
increase in VT and _VE at 8% O2 observed after exposure
to chronic hypoxia in Epo-TAgh mice disappeared after
SMTC injection (Table 1). As observed in WT mice (but
with lower amplitude) it seems, therefore, that nNOS and
NOx could be partially involved in HVR after chronic
hypoxia in Epo-TAgh mice.
Role of NMDA-R on ventilatory control in hypoxia
The injection of MK-801 had no effect on _VE in Epo-TAg
h
mice. However, significant and opposite changes were
observed on VT and fR suggesting that NMDA-R are
involved in the regulation of the ventilatory pattern in
these Epo-deficient mice. Indeed, MK-801 greatly
decreased fR with a concomitant increase in VT at 21 and
8% O2 before and after exposure to chronic hypoxia
(Table 1). This effect of MK-801 in Epo-TAgh mice was the
same, in a larger extent, as the one observed in WT mice
and reinforces the hypothesis of a potential compensatory
mechanism of NMDA-R blockade to maintain baseline
ventilation before and furthermore after chronic hypoxia.
In Epo-TAgh mice, NMDA-R antagonist had no signifi-
cant effect on ventilation when compared to vehicle
despite a significant difference after SMTC injection
(Fig. 3). This result suggests that NMDA-R seems to be
also partially involved in HVR in Epo-TAgh mice.
Conclusion
This study provides evidence that nNOS is partially
involved in VAH in Epo-TAgh mice. NMDA receptors are
increased in the medulla of Epo-TAgh mice exposed to
2014 | Vol. 2 | Iss. 2 | e00223
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chronic hypoxia and could also be involved in VAH.
Moreover, NMDA receptors are crucial for HVR. These
results are, therefore, consistent with the hypothesis of
central nervous system plasticity not only partially involv-
ing nNOS for VAH and requiring NMDA receptors for
HVR and VAH, but also with a potential important cata-
lyzing role of Epo.
Translational perspective
The erythropoietic system is known to stimulate produc-
tion of red blood cells in hypoxic conditions. Besides this
well-known role, Epo synthesised by neurons and astro-
cytes modulates the ventilatory response to hypoxia. This
effect has been attributed to the presence of Epo receptors
in both brainstem respiratory centres and carotid bodies
but little is known regarding the mechanisms involved in
hypoxic ventilatory response and ventilatory acclimatisa-
tion to hypoxia. Using Epo-deficient mice, we showed
that Epo could play a key-regulating role in the neural
control of ventilatory acclimatisation to hypoxia and hyp-
oxic ventilatory response probably via a catalysing role on
the nitric oxide central pathway. These novel findings are
relevant to better understand the respiratory regulations,
especially those occurring during Epo deficiency.
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